Pancrelipase Pregnancy and Breastfeeding Warnings

Pancrelipase is also known as: Cotazym, Creon, Kutrase, Lapase, Lipram, Panase, Pancrease, Pancrease MT, Pancrease MT 10, Pancrease MT 16, Pancrease MT 20, Pancrease MT 4, Pancreaze, Pertzye, Plaretase, Protilase, Ultrase, Ultrase MT 18, Ultresa, Viokace, Viokase, Viokase 16, Viokase 8, Zenpep, Zymase

Pancrelipase Pregnancy Warnings

Pancrelipase has been assigned to pregnancy category C by the FDA. Animal reproduction studies have not been conducted with pancrelipase. It is not known whether pancrelipase can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. The risk and benefit of pancrelipase should be considered in the context of the need to provide adequate nutritional support to a pregnant woman with exocrine pancreatic insufficiency. Adequate caloric intake during pregnancy is important for normal maternal weight gain and fetal growth. The manufacturer recommends caution when administering pancrelipase during pregnancy.

Pancrelipase Breastfeeding Warnings

There are no data on the excretion of pancrelipase into human milk. The risk and benefit of pancrelipase should be considered in the context of the need to provide adequate nutritional support to the nursing mother with exocrine pancreatic insufficiency. The manufacturer recommends that caution be used when administering pancrelipase to nursing women.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web3)